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ABSTRACT 31p cross-polarization/magic angle sample spinning nuclear magnetic resonance spectra have been obtained for pyridoxal
5'-phosphate (PLP) bound to glycogen phosphorylase b (GPb) in two different crystalline forms, monoclinic and tetragonal. Analysis of
the intensities of the spinning sidebands in the nuclear magnetic resonance spectra has enabled estimates of the principal values of the
31p chemical shift tensors to be obtained. Differences between the two sets of values suggest differences in the environment of the
phosphate moiety of the pyridoxal phosphate in the two crystalline forms. The tensor for the tetragonal crystalline form, T state GPb, is
fully consistent with those found for dianionic phosphate groups in model compounds. The spectrum for the monoclinic crystalline form,
R state GPb, although closer to that of dianionic than monoanionic model phosphate compounds, deviates significantly from that
expected for a simple dianion or monoanion. This is likely to result from specific interactions between the PLP phosphate group and
residues in its binding site in the protein. A possible explanation for the spectrum of the monoclinic crystals is that the shift tensor is
averaged by a proton exchange process between different ionization states of the PLP associated with the presence of a sulfate ion
bound in the vicinity of the PLP.
INTRODUCTION
Glycogen phosphorylase is an allosteric protein that cata-
lyzes the first step in the degradation ofglycogen, involv-
ing the phosphorylysis ofglycogen to produce glucose- I-
P ( 1 ). The protein consists ofidentical subunits ofmolec-
ular weights of 100 kD assembled in dimers or
tetramers depending on the conditions under which the
protein exists. For example, in the presence ofactivators,
glycogen phosphorylase dimers associate to form tetra-
mers, but these dissociate back to dimers in the presence
of glycogen or oligosaccharide. Evidence for dimer and
tetramer formation has been reviewed by Dombradi (2).
Glycogen phosphorylase may exist in an active con-
formation (R state) or an inactive conformation (T
state). Active conformations can be achieved by two sep-
arate methods that involve different modifications to
glycogen phosphorylase b (GPb).I The first method is a
covalent modification of GPb to form glycogen phos-
phorylase a. The modification is a phosphorylation of
the serine- 14 residue ofGPb catalyzed by phosphorylase
kinase. The second method of activation is by a non-
covalent association of GPb with an allosteric effector.
Studies on the allosteric activation by effectors have been
reviewed recently (3).
Several allosteric effector sites have been character-
ized, and varying extents of activation can be achieved
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with different effector molecules. For example, phos-
phorylase b can be activated by the non-covalent associa-
tion of the enzyme with the allosteric effector adenosine
5'-monophosphate (AMP) to an active conformation
with high substrate affinity (4). However, in the pres-
ence of the effector inosine 5'-monophosphate (IMP), a
weak activation of phosphorylase b occurs with no in-
crease in affinity of the enzyme for substrate. Inactive
forms of the protein have been found to result on addi-
tion of one of a number of inhibitors; these include caf-
feine, adenosine diphosphate, adenosine triphosphate,
glucose-6-P, and glucose (5-9).
Crystal structures for the protein from rabbit skeletal
muscle in several different conformations have been de-
termined. Crystals were first obtained in a tetragonal
space group P43212 in the presence ofIMP, and a crystal
structure was refined to 6 A ( 10). Further refinements of
this crystal form to 3 (11), 2.25 (12), and 1.9 A ( 13)
have followed. Crystallization from a 1.1 M ammonium
sulfate solution produces a monoclinic form, space
group P21, the structure of which has been solved and
refined to 2.9 A ( 14). As yet, no structure ofGPb with
AMP has been obtained, a result attributed to the de-
crease in solubility and tendency to aggregation when
the protein is activated (3). However, a structure of
phosphorylase b complexed with a modified cofactor,
pyridoxal pyrophosphate, and with AMP has been re-
ported ( 15 ). In addition, two different structures of gly-
cogen phosphorylase a have been solved: one in the pres-
ence of the inhibitor glucose has been refined to 2.5 A
(16) and one in the presence ofammonium sulfate to 2.9
A resolution ( 17).
In the tetragonal form the GPb is a dimer, whereas the
monoclinic form is a tetramer. However, the overall to-
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FIGURE 1 (a) 31P CP/MAS NMR spectrum of the tetragonal crystalline form of GPb at 161.98 MHz. 40,000 transients were collected using a
200 mg protein sample. The spinning speed was 2.48 kHz. (b) Simulation ofthe spectrum from tensor components of 61 I = 66 ppm, 622 = -15 ppm,
633 = -41 ppm, and bi,.w = 3.4 ppm; and Lorentzian broadening of 50 Hz and Gaussian broadening of 800 Hz was used.
pology of the subunits in the two crystalline forms is
similar. Each subunit consists of two domains: one con-
sisting of residues 19-484 and the other of residues 485-
842. The significant differences between the two struc-
tures are in those regions that are important for allosteric
response or are in regions that are part of the tetramer
interface ofthe monoclinic form. The N-terminal 18 resi-
dues are ordered in the monoclinic crystals, an active
state ofthe protein, but disordered in the tetragonal crys-
tals, an effectively inactive state of the protein. Small
structural changes are observed at the ligand-binding
sites and the subunit interface regions in the monoclinic
form in comparison with the tetragonal form; however,
no relative movements between the two domains of the
subunit were found. Significant differences at the alloste-
ric effector sites and the phosphorylated serine residue
site (Ser 14) are thought to be a consequence ofextensive
quaternary structural changes. In addition, some
changes at the catalytic site and inhibitor site can be seen
and are attributed to indirect effects of conformational
changes ( 14).
Activity studies on phosphorylase reconstituted with
modified pyridoxal phosphate (PLP) identified the PLP
as an essential cofactor for activation ( 18). PLP is cova-
lently bound to the protein, the aldehydic group of the
cofactor forming a Schiff base linkage to Lys680. The
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FIGURE 2 (a) 31p CP/MAS NMR spectrum of the monoclinic crystalline form ofGPb at 161.98 MHz. 100,000 transients were collected using a
50 mg protein sample. The spinning speed was 3.95 kHz. (b) Simulation ofthe spectrum from tensor components of 611 = 54 ppm, 622 = -5 ppm,
633 = -42 ppm, and bi6 = 2.0 ppm; and Lorentzian broadening of 200 Hz and Gaussian broadening of 700 Hz was used.
5 '-phosphate was found to be of particular importance,
and 31P nuclear magnetic resonance (NMR) studies
have shown that the resonance ofthis group shifts 3 ppm
downfield on activation of the protein (19-21). These
studies of the protein in solution have been interpreted
to show that the PLP phosphate group is monoanionic
when the protein is inactive and that the transformation
to an active protein is accompanied by a deprotonation
of the phosphate group to a dianionic state.
In this study we describe 31P magic angle sample spin-
ning (MAS) NMR experiments on both the monoclinic
and tetragonal crystal forms of phosphorylase. These
forms were chosen to be identical to those whose struc-
tures had been solved and are thought to represent active
(R) and inactive (T) states ofthe protein and to provide
an opportunity to correlate the observations of solution
behavior with the crystallographic information.
MATERIALS AND METHODS
The nucleotides used in the preparation and purification ofthe protein
and for 31P NMR studies were purchased from Sigma Chemical Co.
Ltd. (Poole, UK). For 31P NMR studies the nucleotides were used
either as received or were recrystallized from water or water/methanol
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TABLE 1 Isotropic and anisotropic 31P NMR chemical shift data
31P solid state
NMR isotropic
chemical shift 5,, 622 633 A
ppm
Tetragonal crystalline
form ofGPb 3.4 ± 0.2 66 ± 1 -15 ± 3 -41 ± 3 107 ± 4 0.42 ± 0.03
Monoclinic crystalline
formofGPb 2.0 ±0.2 54±2 -5±8 -42±8 96± 10 0.7±0.1
PLP (free acid) -1.72 ± 0.02 67 ± 3 7 ± 3 -79 ± 1 146 ± 4 0.78 ± 0.02
IMP (disodium salt) 2.71 ± 0.05 64 ± 1 -16 ± 3 -40 ± 3 104 ± 4 0.39 ± 0.03
mixtures. The nucleotides were confirmed to be ofthe same crystalline
form as in the literature structures by x-ray powder diffraction.
Purification of GPb and crystal growth
GPb was isolated from rabbit skeletal muscle as first reported by
Fischer and Krebs (22) with modifications described by Barford (23).
Two methods were used to obtain crystalline protein. Tetragonal crys-
tals were grown in the presence of 2 mM IMP (10). Crystals were
obtained after 3 wk and rinsed extensively in a phosphate free buffer to
remove free and non-covalently bound phosphates (at 2 mM, IMP is
bound with very low occupancy [24]). This was achieved by soaking
the crystals in a buffer of 10 mM (N,N-bis[2-hydroxyethyl]-2-amino-
ethanesulfonic acid) (BES), 0.5 mM ethylenediaminetetraacetate,
0.02% NaN3, at pH 6.8 for 3 h and then removing the buffer and
replacing it with a fresh buffer. The rinsing was performed six times
over 2 d.
Monoclinic crystals were grown in a 1.1 M ammonium sulfate solu-
tion (14). Crystals were obtained after 1 month and were again rinsed
extensively in a phosphate free buffer to remove free and non-cova-
lently bound phosphates. This was achieved by dialyzing in a buffer of
10 mM BES, 1 M ammonium sulfate, pH 7.5, at 160C for 2 d, with
fresh buffer each day. The crystals were then rinsed by the repeated
removal and addition of phosphate free buffer every hour for 5 h. The
crystals were then left in buffer overnight.
The crystals were verified to be of the correct crystalline form by
checking their morphology under a microscope. The protein was
packed into a zirconia rotor after removing the surface solvent on filter
paper.
Solid state NMR spectroscopy
31P solid state NMR spectra of GPb and some ofthe model phosphate
compounds were recorded on a (model MSL400; Bruker Instruments,
Karlsruhe, Germany) pulse spectrometer with a 9.4 T wide bore super-
conducting solenoid magnet (Oxford Instruments, Oxford, UK) oper-
ating at a frequency of 400.13 MHz for 'H. The instrument was
equipped with an Aspect 3000 data system. The 31P NMR spectra were
recorded at a frequency of 161.98 MHz using a multinuclear, proton-
enhanced, double-bearing MAS probe and a high power proton de-
coupler. All the spectra were referenced externally to 85% H3PO4 at 0
ppm, positive chemical shift values being taken as downfield of this
reference.
Solid state NMR techniques of cross polarization (CP) along with
MAS and high power proton decoupling were used to obtain all the
spectra. The samples were packed into 7 mm diameter zirconia rotors
with Kel-F tops. Typical rf fields used for 'H were 0.9 mT (w, = 38.5
kHz), resulting in a 900 pulse length of 6.5 Ms. Contact times of 1 ms
were used with a recycle delay of 3 s. Typical MAS speeds were 2-4
kHz. The samples were spun with great care to ensure stability in the
spinning rate to within ±3 Hz. All spectra were recorded at ambient
temperature.
Additionally, 31P CP/MAS NMR spectra of the nucleotides were
also recorded on a Bruker MSL200 pulse spectrometer with a 4.7 T
wide bore magnet operating at a frequency of 200.13 MHz for 'H,
81.02 MHz for 31p, using a similar probe. Typical rf fields used for 'H
on the MSL200 were 1.3 mT (c, = 55.5 kHz), resulting in a 900 pulse
length of 4.5 Ms. Approximately 100-500 transients were taken for the
spectra ofnucleotides and -200 mg ofsample used in the experiments.
Determination of chemical shift
tensors
The spinning sideband manifold ofthe MAS NMR spectrum contains
information regarding the chemical shift tensor. Initial values for the
principal components of the chemical shift anisotropy (CSA) tensor,
61 1, 622, 633, were determined using a computer program written by Dr.
M. M. Maricq (25) and modified by Dr. N. J. Clayden (25a). (The
convention 6(,, > 622 > 633 is used.) The program is based on the mo-
ment analysis of Maricq and Waugh (25) and uses the intensity profile
ofthe MAS NMR spectrum and the isotropic chemical shift value, bi,o.
The values ofthe principal components were then put through an itera-
tive test using a downhill simplex method of analysis to minimize the
difference between the intensity profile of the experimental and simu-
lated spectra using a program FSPIN written by Dr. N. J. Clayden and
modified by Dr. J. M. Twyman (Oxford University). The tensor infor-
mation was then used to evaluate the MAS NMR spectrum at any
particular MAS rate. Slight modifications to the tensor were made to
simulate a spectrum that best represented the experimental spectrum.
The chemical shift anisotropy term, A, which is the spread of the CSA
powder pattern, is defined in terms of the principal components as
A = - 633-
The asymmetry parameter is defined by
n = ((5, - 622)/(.i -633) if (i - 633) > (611- i.)
and by
X = (622 - 633)/(611i- ) if (i - 633) < ((, - is)-
RESULTS
31P CP/MAS NMR spectra ofthe tetragonal and mono-
clinic crystalline forms ofGPb are shown in Figs. 1 a and
2 a, respectively. Despite the broad linewidths and the
limited signal-to-noise ratios associated with detecting
one 31P nucleus in a protein of 100 kD molecular weight,
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FIGURE 3 (a) 31pCP/MAS NMR spectrum ofthe free acid ofpyridoxal 5'-phosphate (PLP) at 81.02 MHz. 60 transients were collected using a 200
mg sample. The spinning speed was 1.53 kHz. (b) Simulation of the spectrum from tensor components of 6,I = 67 ppm, 622 = 7 ppm, 633 = -79
ppm, and bi6, = -1.72 ppm; and Lorentzian broadening of 50 Hz and Gaussian broadening of 70 Hz was used.
the spectra were of sufficient quality to show clearly up
to fourth and second order sidebands, respectively, for
the two crystal forms. The intensities of the sidebands
were sufficiently well defined to be used in analyses to
determine principal values of the chemical shift tensors;
the results are shown in Table 1. The resulting tensor
values were used to simulate MAS spectra for the respec-
tive crystalline forms of the protein. These spectra are
shown in Figs. 1 b and 2 b for the tetragonal and mono-
clinic crystalline forms, respectively.
The spectra are typical of MAS NMR with a single
isotropic peak in each spectrum flanked on either side by
a series of sidebands at intervals of the spinning fre-
quency. The two spectra were acquired at different spin-
ning speeds, 2.48 and 3.95 kHz, for the tetragonal and
monoclinic forms, respectively. The conditions under
which the monoclinic crystals are grown are more sensi-
tive than those for the tetragonal form, resulting in diffi-
culties in producing large quantities of material for
study. Only 50 mg of the monoclinic form was used,
whereas 200 mg of the tetragonal form was used in the
NMR experiments. A higher MAS rate was used for the
monoclinic crystals to optimize the signal-to-noise ratio,
albeit at the expense of fewer sidebands for analysis. Re-
peated spectroscopy on the same batch of material
showed increased resonance linewidths, indicating that
the crystallinity of the protein crystals degrades within
-1 wk of removal of crystals from the mother liquor.
The phosphate ofthe PLP in both tetragonal and mono-
clinic crystalline forms is buried 15 A from the surface
ofthe enzyme and is rather shielded from the bulk water
of the solvent ( 13, 14); removal of the protein crystals
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FIGURE 4 (a) 3"PCP/MAS NMR spectrum ofthedisodium saltofinosine 5'-monophosphate (IMP) at 161.98 MHz. 100 transientswere collected
using a 200 mg sample. The spinning speed was 3.03 kHz. (b) Simulation ofthe spectrum from tensor components of 611 = 64 ppm, 622 = -16 ppm,
633 = -40 ppm, and 6j. = 2.71 ppm; and Lorentzian broadening of 70 Hz and Gaussian broadening of 30 Hz was used.
from the solvent is therefore unlikely to remove essential
water molecules needed to maintain the conformation
about the PLP.
The rather broad inhomogeneous linewidths of - 800
Hz and the Gaussian lineshape of the resonances of the
fresh crystals are presumed to result from a spread of
environments for the phosphate group in the crystalline
protein. The isotropic chemical shifts could, however, be
determined to within -0.2 ppm; they were 3.4 and 2.0
ppm for the tetragonal and monoclinic forms, respec-
tively.
Several mononucleotides were studied as model phos-
phate monoester compounds for tensor analyses. The
nucleotides selected for experiments all had known crys-
tal structures. Some tensor analyses have already ap-
peared in the literature for mononucleotides (26), but
we have repeated a number of these and studied some
new ones to test our method of tensor determination.
Disodium salts of the nucleotides were used for model
dianionic phosphate monoesters. Free acids were used
for model monoanionic phosphate monoesters as struc-
ture determination has shown most to be zwitterionic,
such that the phosphate group is a monoanion and the
base is protonated (27-34).
The crystalline nucleotides have much narrower
NMR linewidths of typically <100 Hz in comparison
with 800 Hz for the protein spectra, suggesting a greater
homogeneity ofthe environment ofthe phosphate group
in the small molecule crystals than in the protein. The
31P CP/MAS NMR spectrum of the free acid of pyri-
doxal 5 '-monophosphate, in its monoanionic state (3 1 ),
is shown in Fig. 3 a, and the simulated spectrum, from
the tensors determined and listed in Table 1, is shown in
Fig. 3 b. No crystal structure is available for the dianionic
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form of this compound. The principal values ofthe ten-
sor for the disodium salt of IMP, an example of one of
the model dianionic phosphate monoester compounds,
were however determined and are listed in Table 1. The
experimental and simulated 31P CP/MAS NMR spectra
are shown in Fig. 4, a and b, respectively.
DISCUSSION
31P NMR chemical shifts of organic phosphates in solu-
tion have been empirically correlated to O-P-O bond an-
gles, bond orders, and substituent electronegativities
(35, 36). Protonation or esterification of the tetrahedral
P043- group perturbs the electron density distribution
about the phosphorus nucleus and alters the O-P-O bond
angles and P-O bond lengths. The chemical shift is there-
fore dependent on the overall ionization state ofthe phos-
phate group.
Examination of isotropic chemical shifts in solution
and in the solid state ofmonoanionic and dianionic phos-
phate monoesters presented here and in the literature
(37-45) reveals a general shift downfield of -5 ppm on
changing from a monoanionic to a dianionic phosphate
group. The isotropic chemical shifts ofphosphates in the
solid state are similar to those in solution state; very
minor differences may well be due to effects on the O-P-
0 bond angle that are induced on crystallization.
Studies on the PLP cofactor of GPb in solution by
NMR have found a similar change in chemical shift on
activation ofthe protein. A shift of 3 ppm downfield was
interpreted as resulting from a change from a monoan-
ionic to a dianionic phosphate group when the protein is
activated (20, 21). The solid state isotropic chemical
shifts ofGPb in the two crystalline forms are in the same
range as the isotropic chemical shifts for the PLP ofGPb
in solution, but a smaller difference between chemical
shifts for the two crystalline forms is observed than is
typical for a change in ionization state. The chemical
shift of the tetragonal crystalline form of GPb is nearly
identical to the dianionic chemical shift in solution. The
chemical shift ofthe monoclinic crystalline form ofGPb
is intermediate between that expected for a monoan-
ionic and a dianionic phosphate group.
It has been shown that the principal axes of the 31p
chemical shift tensor relate simply to the ground state
electron density distribution in the molecule. The princi-
pal components of the chemical shift tensor of phos-
phate groups were found from single crystal studies (39-
41, 46) to lie roughly along the P-O bond directions,
such that the most downfield component (b6I) lies along
the plane of lowest electron density, the most upfield
component (633) lies along the plane of highest electron
density, and the third component (622) lies along the bi-
sector of the bond angle of the P-O bonds of highest
electron density. A compilation of chemical shift aniso-
tropies (26) and our studies (Taguchi, J. E., S. J. Heyes,
and C. M. Dobson, unpublished data) have shown that
the components of the principal values of the tensor for
monoanionic phosphate monoesters have ppm values in
the range of70 ± 7 for 6, 6 ± 5 forb22, and -80 ± 10 for
633. The principal values ofthe tensor for dianionic phos-
phate monoesters showed the components to have val-
ues in the range of 70 ± 8 for 61, -22 ± 7 for 622, and
-31 ± 9 for633.
The principal values of the 31p chemical shift tensor
used to simulate the spectrum of tetragonal GPb show
close similarities to those of the dianionic phosphates
presented here and in the literature. In particular the
asymmetry parameter, i7 = 0.42, is consistent with that
(<0.5) expected for a dianion and the anisotropy, A =
611 - 633 = 107 ppm, is in the middle ofthe range shown
by model dianionic organic phosphate compounds. The
622 values appear to correlate with the formal charge on
the phosphate; mono- and dianionic states fall in the
particular ranges of 1-11 ppm and -29 to -15 ppm,
respectively. The 622 value (-15 ppm) for PLP in tetra-
gonal crystals of GPb, therefore, falls into the range for
dianionic phosphates. The principal values of the tensor
and the simulation ofthe MAS spectrum from these val-
ues are, like the isotropic chemical shift, effectively iden-
tical to those found for dianionic rather than monoan-
ionic phosphate groups in model compounds. As the te-
tragonal crystal structure has been suggested to be a T
state for this form of GPb, since it was obtained in the
presence ofIMP (10) and shows close similarities to the
structure ofT state (inactive) glycogen phosphorylase a
(47), the observation that the 31p spectrum of PLP in
this crystal form is fully consistent with a dianionic state
is surprising from the point ofview ofthe solution NMR
data. This observation is not, however, inconsistent with
the crystal structure; examination of the PLP environ-
ment shows contacts to the PLP phosphate from Lys 568
and two peptide NH groups from the helix (shown in
Fig. 5 a), which would be reasonable for a dianion. Fur-
thermore, a similar conclusion ofa dianionic phosphate
has been arrived at, independently, by Challoner et al.
(48) for crystalline phosphorylase obtained in the pres-
ence of glucose under conditions similar to those for
which 31p solution NMR has been carried out and the
protein shown, in solution, to be in a T state.
The 31p CP/MAS NMR spectrum of the monoclinic
crystalline GPb form differs significantly from that ofthe
tetragonal form. Although the principal values ofthe sim-
ulated tensor are closer to those ofdianionic than mono-
anionic model compounds, simulation ofthe MAS spec-
trum from a single tensor produces a less satisfying fit
than was obtained for the tetragonal form as shown in
Fig. 2 b. The main differences between the experimental
and simulated spectra are in the second order sidebands,
which are more intense in the experimental spectrum
than in the simulated ones. The possibility of a superpo-
sition ofsidebands corresponding to two tensors, one for
a monoanionic phosphate and one for a dianionic phos-
phate, was tested by simulating a series ofmixtures ofthe
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FIGURE 5 Stereo diagrams of the environment ofthe pyridoxal phosphate 5'-phosphate group in tetragonal and monoclinic crystalline forms of
GPb. The phosphate and the sulfate groups are labeled P and S, respectively, in the left-hand image of the stereo diagrams. Water molecules are
shown as circles with black dots. (a) Tetragonal crystalline form ofGPb (T state) (13). The structure has been refined at 1.9 A resolution which
allows for the definite location ofwater molecules. The cofactor phosphate is solvated with direct contacts to five water molecules, four ofwhich are
shown here. The major protein hydrogen bond contacts are from main chain nitrogens ofThr676 and Gly677 at the start ofan a helix and from one
basic group, NZ Lys568. Each of these groups and water molecules are involved in extensive hydrogen bond networks. One of the phosphate
oxygens is hydrogen bonded through two water molecules to the side chain of an acidic residue, Asp283. Two other ionisable groups, Lys574 and
Glu672, are in the vicinity but are too far away to make direct contacts to the cofactor phosphate. Main chain atoms only are shown for residues
676-678. Part ofthe side chain ofLys680 and the glycine loop residues 133-136 have been omitted for clarity. (b) Monoclinic crystalline form of
GPb (R state) (14). The structure determination at 2.8 A resolution does not permit definite assignment ofwaters, and these are not included. The
cofactor phosphate makes rather long hydrogen bond contacts to the main chain nitrogens of Thr676 and Gly677. There is a sulfate ion directly
hydrogen bonded to the cofactor phosphate. The loop containing Asp283 and Asn284 is displaced, and the side chain ofArg569 has swung down
from the T state position to contact the sulfate.
two states using typical tensor values obtained from the
model compounds. This procedure resulted in little im-
provement in the comparison between experimental and
calculated spectra and provided no evidence for the exis-
tence of a simple physical mix of two ionization states,
either from two species ofprotein or from residual phos-
phate from the purification ofthe protein. Furthermore,
the possibility of additional phosphate signal arising
from residual AMP has been ruled out using absorbance
measurements at 260 and 280 nm, which indicated the
sample was AMP free. Also, experiments have been
carried out on a sample where adenosine 5 '-O-thiomono-
phosphate (AMPS) was used in place of AMP in the
preparation and purification of GPb. 31P NMR studies
of this crystalline sample showed no sign ofAMPS pres-
ent in the sample (unpublished data). AMPS binds
more tightly to the GPb than AMP, so the possibility of
residual phosphate arising from the presence ofthe latter
is highly unlikely. In the light of the excellent fit of the
MAS spectra for tetragonal GPb and the model nucleo-
tides to single tensor interactions, the less good fit for the
monoclinic GPb to either a single tensor interaction or a
weighted sum of two independent interactions suggests
that the shielding ofthe 31P nucleus in this system cannot
be described fully by a single discrete tensor.
The monoclinic crystals are grown in an ammonium
sulfate solution; it has been shown that at high concen-
trations of ammonium sulfate in solution, the protein
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may be activated (49). Hence, an R state (active) of
GPb is expected and a dianionic PLP expected from so-
lution 31P NMR studies. The possibility exists that local
interactions within the protein perturb the tensor signifi-
cantly from that expected for this ionization state such
that it differs from that found for model compounds.
There is, however, also a possibility that averaging ofthe
tensor occurs. Some evidence that the latter may be an
explanation comes from the observation of the anisot-
ropy, A = 6 I - 633 = 96 ppm, of the "best-fit" tensor.
This is significantly less than that typical of dianionic
phosphates and considerably less than that for monoan-
ionic phosphates. A possible explanation for the appear-
ance of the monoclinic spectrum is therefore that the
phosphate group exists in monoanionic as well as dian-
ionic forms that are in dynamic equilibrium. Dynamic
averaging ofthe phosphate system will tend to reduce the
chemical shift anisotropy from the values for the static
forms, as observed experimentally, and would be consis-
tent with the 622 value ofthe best-fit tensor lying between
that expected for monoanionic and for dianionic phos-
phates. If such a dynamic process were to exist and were
to be ofa rate in the intermediate range ofthe CSA time-
scale, then the spectrum would need to be calculated
explicitly (50). The resultant sideband manifold intensi-
ties will not in general fit to a tensor interaction.
Challoner et al. (48) have concluded that dianionic
PLP is present in their crystalline form ofGPb, which is
expected to be in an R state based on the activity of the
protein in solution under conditions used to grow their
crystals where AMPS was used as an activator. An exami-
nation ofthe crystal structure for the monoclinic form of
GPb ( 14) shows that a sulfate anion is bound very near
(circa 5 A) to the phosphate group of the PLP cofactor,
within H-bonding distance (shown in Fig. 5 b). The pres-
ence of the sulfate anion could alter the environment of
the phosphate group, either influencing the shift tensor
directly or perturbing the protonation state of the phos-
phate. One possibility, for example, is that the effective
pK value of the phosphate group could be increased, to
become closer to that of the pH of the crystals (7.5). A
proton could then be in equilibrium between its site on
the phosphate group and a nearby residue or the solvent.
Such an equilibrium process could account for the ob-
servations by 31p solid state NMR in this work and dif-
ferences to those observations by Challoner et al. (48).
In conclusion, the solid state 31P NMR experiments
described here have enabled the nature ofthe phosphate
group ofthe PLP cofactor ofGPb to be examined under
conditions where x-ray structural determinations have
been carried out. For the tetragonal (T state) crystals, the
phosphate group is demonstrably in a dianionic state.
This observation can be rationalized in terms ofthe crys-
tal structure, as the phosphate makes several contacts
with the protein, including direct interaction with a ly-
sine and two main chainNH groups from the start ofthe
a-helix. These contacts to the PLP do not change, al-
though other interactions through water to an aspartate
residue are altered during the T to R state transition. In
accord with this, despite the presence ofsulfate ion in the
monoclinic (R state) crystals, the PLP appears also to be
predominantly in a dianionic state, although there is evi-
dence for proton exchange between dianionic and mono-
anionic states in this crystalline form. This suggests that,
at least under the conditions used in this study and the
crystal structure determinations, the transition between
forms ofthe protein designated as T and R is not accom-
panied by a simple change in ionization state ofthe pyri-
doxal phosphate group.
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